Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

NCT01196988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3027

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza vaccine GSK2321138A
BIOLOGICAL: FluarixTM
BIOLOGICAL: Influenza vaccine GSK2604409A

Sponsor

GlaxoSmithKline